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Background: The burden of patients with heart failure on health care systems is widely recognised, although there
have been few attempts to quantify individual patterns of care and differences in health service utilisation related to
age, socio-economic factors and the presence of co-morbidities. The aim of this study was to assess the typical
profile, trajectory and resource use of a cohort of Australian patients with heart failure using linked population-
based, patient-level data.
Methods: Using hospital separations (Admitted Patient Data Collection) with death registrations (Registry of Births,
Deaths and Marriages) for the period 2000–2007 we estimated age- and gender-specific rates of index admissions
and readmissions, risk factors for hospital readmission, mean length of stay (LOS), median survival and bed-days
occupied by patients with heart failure in New South Wales, Australia.
Results: We identified 29,161 index admissions for heart failure. Admission rates increased with age, and were
higher for males than females for all age groups. Age-standardised rates decreased over time (256.7 to 237.7/
100,000 for males and 235.3 to 217.1/100,000 for females from 2002–3 to 2006–7; p = 0.0073 adjusted for gender).
Readmission rates (any cause) were 27% and 73% at 28-days and one year respectively; readmission rates for heart
failure were 11% and 32% respectively. All cause mortality was 10% and 28% at 28 days and one year. Increasing
age was associated with more heart failure readmissions, longer LOS and shorter median survival. Increasing age,
increasing Charlson comorbidity score and male gender were risk factors for hospital readmission. Cohort members
occupied 954,888 hospital bed-days during the study period (any cause); 383,646 bed-days were attributed to heart
failure admissions.
Conclusions: The rates of index admissions for heart failure decreased significantly in both males and females over
the study period. However, the impact on acute care hospital beds was substantial, with heart failure patients
occupying almost 200,000 bed-days per year in NSW over the five year study period. The strong age-related trends
highlight the importance of stabilising elderly patients before discharge and community-based outreach programs
to better manage heart failure and reduce readmissions.
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Heart failure is associated with considerable morbidity and
poor survival. It is characterised by numerous hospital
readmissions and extensive use of health care resources
[1-3]. The resulting substantial burden on health care sys-
tems and the associated costs are a consequence of ageing
populations and improvements in the medical manage-
ment of heart failure with the use of therapies such as
beta-blockers, ACE inhibitors, aldosterone inhibitors and
device therapies that prolong survival after ischaemic heart
damage or heart failure related to hypertension and valvu-
lar heart disease.
There has been limited documentation of the health sys-
tem impacts of heart failure in the Australian community.
Morbidity estimates have typically been derived by applying
international chronic heart failure incidence and prevalence
data to Australian population estimates [4]. More direct
estimates have been derived from the National Hospital
Morbidity Data (NHMD) collection [5]. This information,
however, is based on aggregated data collections, with no
analysis at individual patient level.
Patient-level data are required to examine individual
patterns of care, and differences in outcomes related to
age, socio-demographic factors, and the presence of co-
morbidities. In Australia, there is universal, publicly funded
coverage for hospital and community-based medical ser-
vices. Consequently, there are a number of administrative
data sets that provide comprehensive coverage of patients
with heart failure at the national or state level. Most experi-
ence with the analysis of linked health data-sets has been in
Western Australia, which has validated the use of adminis-
trative data to identify patients with heart failure [6]. Al-
though the rate of index hospital admission has fallen, the
burden of disease has increased because of improved sur-
vival and the ageing of the community [7].
A capacity for linkage of publicly funded health adminis-
trative data sets at the level of the individual patient has re-
cently become available in Australia’s most populous state,
New South Wales (NSW). To inform planning for care of
individuals in NSW suffering from heart failure we per-
formed an analysis of the NSW linked data-sets. We mea-
sured the rates of index (first) admissions for heart failure,
the readmission rates, mortality and median survival from
first admission. To assess the burden of disease on the
healthcare system, we examined the average length of stay
(LOS) for the index admission, readmissions in the first
year, and the impact of co-morbidities on readmission
rates. Finally, we calculated the bed-days occupied by
patients with heart failure during the study period.
Methods
Access to the relevant NSW data-sets was through the
Centre for Health Record Linkage (CHeReL; http://www.
cherel.org.au).Data sets
Records were drawn from the NSW Admitted Patient
Data Collection (APDC; representing all separations in
public and private hospitals in NSW, including dis-
charges, transfers and deaths) between 1 July 2000 and
30 June 2007; and death registrations (fact of death) in
the NSW Registry of Births, Deaths and Marriages
(RBDM) for the years 2000–2007.
Definitions
Heart failure cohort
The cohort comprised all NSW residents aged ≥45 years
with a first (index) admission for heart failure i.e. a princi-
pal hospital discharge (separation) code for heart failure
(ICD-10 code I50) or hypertensive heart disease (I11, I13)
in the APDC between 1 July 2002 and 30 June 2007.
Hypertensive heart disease was included in the definition
based on evidence that some cases of heart failure are clas-
sified under this rubric [8].
Index admission for heart failure
An index admission was defined by the absence of a
heart failure separation code (any diagnostic position) in
the two years prior to the eligible admission.
Readmissions
Readmissions were counts of patients re-presenting at
NSW hospitals for any cause within one month (28 days)
and one year after the index admission for heart failure.
Heart failure readmissions were any readmission where
the principal separation code was heart failure (I50) or
hypertensive heart disease (I11, I13).
Co-morbidities
We used the validated Charlson Index as a co-morbidity
measure using an algorithm based on the work of
Sandarajaran [9]. Given that heart failure is included in
the Charlson Index and all patients had heart failure, no
point was given for this. Co-morbidities were assessed in
two ways: firstly, by examining hospital separation codes
(all positions) at the index admission; and secondly by in-
cluding separation codes from the index admission and all
admissions in the two years prior to the index admission
combined.
Burden of disease
We calculated actual bed-days occupied due to index
admissions and readmissions.
Geography
Geography was defined using the Accessibility/Remote-
ness Index of Australia (ARIA) [10].
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Socio-economic status was defined using the SEIFA (Socio-
Economic Indexes for Areas) Index [11] based on 2006
Australian Census responses, and divided into quintiles.Data linkage
We used extracts of linked hospital separation data from
the APDC with RBDM death registrations with encryp-
tion to protect the identity of individual patients. Data
linkage by the CHeReL uses probabilistic matching of
patients’ names and other identifiers with ChoiceMaker
software [12], supplemented with clerical review of
doubtful matches.Statistical methods
Age-specific rates of index (first) admissions for heart
failure or hypertensive heart disease to public and private
hospitals in NSW (1 July 2002–30 June 2007) were cal-
culated by dividing the number of index events in 5-year
age groups by the NSW population in that age group in
that year. Age-standardised rates and 95% confidence
intervals were calculated for each year using the indirect
method with the 2006 NSW census population as the
reference. Trends over time were examined with linear
regression models.
The proportions of patients with a readmission (any
cause or heart failure) in the first month (28 days) and
first year post-index admission were calculated for the
whole population and by 5-year age groups. The prob-
abilities of readmission at one-month and one-year were
estimated using Kaplan-Meier curves and the log rank
test was used to test for statistically significant differ-
ences between age groups; individuals were censored at
the time they died.
The LOS for the index admission and re-admissions
was summarised as the mean number of days (with
standard deviation), and presented for the whole popula-
tion and by 5-year age groups. Linear regression was
used to examine differences in LOS between age groups,
after adjusting for potential confounding variables (age,
gender, Charlson Index based on hospital separation
codes for the index admission, geography using the
ARIA index, and socioeconomic status using SEIFA
quintiles). LOS data are not normally distributed (highly
skewed to the right) and a robust variance estimator was
used to correct for this. Cox proportional hazards mod-
elling were used to assess the impact of potential risk
factors for readmission to hospital. Where there was a
missing value for any outcome or co-variate, the record
was excluded from the analysis; this affected fewer than
3% of observations in the dataset. We tested the assump-
tion of proportional hazards by examining the graph of
the log(−log(survival)) versus log survival time graph.Mortality rates and median survival time were calcu-
lated from first admission for heart failure or hyperten-
sive heart disease. Survival from index admission to
death was estimated using Kaplan-Meier curves, with
curves fitted by 5-year age groups. The log rank test was
used to test for statistically significant differences be-
tween age groups.
All analyses were done using SAS version V9.1 (SAS
Institute Inc., Cary, NC, USA) and analyses performed at
the 5% significance level.
The study was approved by the NSW Population and
Health Service and University of Newcastle Research
Ethics Committees.Results
There were 14,972,359 hospital separations in the APDC
between 1 July 2000 and 30 June 2007, 67,018 of which
had a principal diagnosis ICD-10 code of I50, I11 or I13,
representing 41,904 persons. Of these, 29,735 persons had
not been hospitalised with these separation codes (any
position) in the two years prior to this event. Removing
the 574 people aged <45 years at the index admission left
29,161 persons (with 645,245 separations) to form the
heart failure study cohort. Patients with hypertensive heart
disease comprised <2% of the study population.Demographic characteristics
Most patients (67.9%) were ≥75 years of age and 28.7%
were aged ≥85 years (Table 1). There were approximately
equal numbers of males and females in the cohort
(14,604 males, 14,557 females). Females represented
around one-third of those aged 45–64 years, but just
under two-thirds (63.5%) of those aged ≥85 years (data
not shown).Comorbidity burden
Patients had a median of 2.0 comorbidities recorded at
baseline admission, although the range was wide (0–13, not
including heart failure), with some evidence of an increase
in comorbidity burden over time (Table 2). Re-calculation
of the Charlson Index from hospital separation codes at the
index admission and all admissions in the previous two
years combined did not change the estimates substantially.
Across the cohort this had the effect of increasing the mean
number of comorbidities per patient by 0.5, with the me-
dian number of recorded comorbidities increasing from 2.0
to 3.0.
The most commonly recorded co-morbidities at the
index admission were diabetes with chronic complica-
tions (27% of patients), pulmonary disease (15.6%), renal
disease (14.2%), dementia (5.9%), acute myocardial in-
farction (5.3%), peripheral vascular disease (4.2%), and
cerebral vascular disease (3.4%).
Table 1 Number and percent of index admissions by gender, age group, marital status, diagnosis and ARIA and SEIFA
indices
2002 – 03* 2003-04 2004-05 2005-06 2006-07
N†=5854 N=5935 N=5606 N=5813 N=5953
n % n % n % n % n %
Sex
Male 2899 50 2924 49 2804 50 2983 51 2994 50
Female 2955 50 3011 51 2802 50 2830 49 2959 50
Age Group
45-49 68 1.2 61 1.0 54 1.0 88 1.5 81 1.4
50-54 114 1.9 136 2.3 105 1.9 127 2.2 122 2.0
55-59 206 3.5 201 3.4 191 3.4 199 3.4 212 3.6
60-64 302 5.2 349 5.9 302 5.4 317 5.5 324 5.4
65-69 472 8.1 463 7.8 478 8.5 423 7.3 408 6.9
70-74 800 14 760 13 683 12 643 11 662 11
75-79 1085 19 1082 18 1019 18 1054 18 1000 17
80-84 1256 21 1205 20 1209 22 1205 21 1316 22
85+ 1551 26 1678 28 1565 28 1757 30 1828 31
Marital Status
Married (including defacto) 2686 46 2755 46 2705 48 2764 48 2797 47
Never married, widowed, divorced, separated 2951 50 2932 49 2692 48 2872 49 3017 51
Unknown 214 3.7 241 4.1 180 3.2 176 3.0 138 2.3
Diagnosis
Hypertensive heart disease (I11, I13) 106 1.8 84 1.4 86 1.5 84 1.4 83 1.4
Congestive heart failure (I50.0) 3918 67 4018 68 3848 69 4151 71 4365 73
Left ventricular failure (I50.1) 1614 28 1633 27 1496 27 1389 24 1283 22
Heart failure, unspecified (I50.9) 216 3.7 200 3.4 176 3.1 189 3.3 222 3.7
ARIA{
Highly Accessible 4264 75 4393 76 4164 76 4315 76 4394 76
Accessible 1159 20 1131 20 1022 19 1081 19 1099 19
Moderately Accessible 206 3.6 194 3.4 217 4.0 186 3.3 178 3.1
Remote / Very Remote 72 1.3 65 1.1 52 1.0 72 1.3 76 1.3
SEIFA{
Most Disadvantaged (1) 784 14 771 13 666 12 759 13 713 12
2 985 17 1005 17 942 17 965 17 1042 18
3 1308 22 1356 23 1292 23 1326 23 1313 22
4 1220 21 1243 21 1242 22 1264 22 1299 22
Most Advantaged (5) 1526 26 1528 26 1438 26 1452 25 1514 26
* Financial Year (1 July – 30 June).
† N=number of persons with index admissions.
{ Data not available for all cohort members.
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for heart failure
The rates of an index admission for heart failure increased
consistently with increasing age; and were higher for males
than females for all age groups (Table 3). Index admission
rates decreased over time; the age-standardised rates for
males decreased from 256.7 to 237.7 per 100,000 from2002–3 to 2006–7 and for women from 235.3 to 217.1/
100,000. These trends over time were statistically signifi-
cant (p =0.0073, adjusted for gender).
Hospital readmissions and deaths
Of the 29,161 patients, 7,415 had a readmission (for any
cause) within 28 days; 18,493 had one or more readmissions
Table 2 Co-morbidity burden assessed by Charlson Index
Variable Statistic 2002 – 03* 2003 - 04 2004 - 05 2005 -06 2006 - 07
(N=5854) (N =5935) (N= 5606) (N = 5813) (N =5953)
Charlson Score mean (sd) 2.2 (1.5) 2.2 (1.5) 2.5 (1.6) 2.3 (1.5) 2.4 (1.6)
(based on index admission) median 2.0 2.0 2.0 2.0 2.0
(q1, q3) (1.0, 3.0) (1.0, 3.0) (1.0, 3.0) (1.0, 3.0) (1.0, 3.0)
Charlson Score mean (sd) 2.7 (1.8) 2.8 (1.9) 3.0 (2.0) 2.8 (1.9) 2.9 (2.0)
(based on two years history) median 2.0 2.0 3.0 3.0 3.0
(q1, q3) (1.0, 4.0) (1.0, 4.0) (1.0, 4.0) (1.0, 4.0) (1.0, 4.0)
* Financial Year (1 July – 30 June).
† N=number of persons with index admissions.
sd = standard deviation; q1,q3 =quartile 1, quartile 3.
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rates of 27% and 73% at 28 days and one year respectively
(Table 4). Readmissions attributed to heart failure were 11%
and 32% at 28 days and one year respectively (Figure 1).
The proportions of readmissions attributed to an exacerba-
tion of heart failure increased with age (Table 5). Heart fail-
ure readmission rates at one year increased by age from
approximately 25% in the 45–49 year age group to 37% in
people aged ≥85 years (data not shown).Table 3 Age-specific and age-standardised rates of index adm
Rate of
5 Year Age group Gender 2002 – 03* 2003
45-49 Male 19.4 16.
n = 352 Female 9.9 9.7
50-54 Male 33.8 37.
n = 604 Female 19.1 25.
55-59 Male 70.8 65.
n = 1009 Female 38.2 37.
60-64 Male 132.8 155
n = 1594 Female 75.8 79.
65-69 Male 236.0 226
n = 2244 Female 152.1 147
70-74 Male 413.8 432
n = 3548 Female 311.9 271
75-79 Male 691.5 678
n = 5240 Female 493.7 486
80-84 Male 1165.3 1092
n = 6191 Female 886.5 799
85+ Male 1950.3 1864
n = 8379 Female 1430.5 1602
Age Standardised Male 256.7 252
(247.4, 266.1) (243.4, 2
Rate Female 235.3 236
(95% CI) (226.8, 243.8) (228.3, 2
* Financial Year (1 July – 30 June).All-cause mortality rates were 10% at 28 days and 28%
at one year (Table 4). As expected, there were age-related
trends, with 28 day and one year mortality increasing
from 4.1% and 13.1% in those aged 45–49, up to 14.9%
and 41.8% in those aged ≥85 years. Median survival after
a heart failure index admission ranged from about 1.5
years in those aged over 85, three years for those aged
80–85, 4 years for those aged 75–79 to even longer for
those younger than 75 (Figure 2).ission by gender and financial year
admission (per 100000 persons aged ≥45 years)
– 04 2004 – 05 2005 – 06 2006 – 07
2 14.7 27.8 20.9
7.9 8.6 12.1
0 30.8 40.6 39.1
9 17.4 17.2 15.5
4 64.5 63.1 67.2
3 30.7 33.8 34.6
.7 131.5 137.3 130.8
3 64.5 60.6 61.9
.2 237.9 211.5 190.1
.5 139.9 116.1 119.0
.9 391.6 357.5 345.8
.6 249.7 247.1 266.8
.1 620.0 686.9 652.6
.3 466.2 442.4 420.4
.9 1026.5 1058.1 1133.1
.5 792.6 729.2 774.5
.6 1781.1 1871.3 1784.9
.6 1393.9 1493.9 1496.0
.6 236.1 244.1 237.7
61.7) (227.4, 244.8) (235.4, 252.8) (229.2, 246.2)
.8 215.7 213.2 217.1
45.2) (207.8, 223.7) (205.4, 221.1) (209.3, 224.9)
Table 4 Patients with specified events and risk for events
within 28 days and 1 year of the index admission











7415 0.27 18493 0.73
Readmission -
heart failure*
3007 0.11 7848 0.32
All-cause
mortality
2531 0.10 6890 0.28
Readmission
or death
9471 0.35 21125 0.79
Readmission
HF or death
5302 0.20 12556 0.49
* heart failure or hypertensive heart disease as principal separation code.
† derived from Kaplan-Meier curves.
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There were strong and statistically significant age-
related trends for LOS for the index admission, readmis-
sions for any cause and heart failure readmissions
(Table 6). Readmissions for heart failure were longer
than readmissions for any cause for the entire cohort
(8.3 versus 4.8 days) and for all age groups. In the case
of those aged ≥85 years, the mean duration of a heart
failure readmission was comparable to that of the index
admission (9 versus 9.6 days).
Burden on hospital health services
There were a total of 954,888 hospital bed-days for any
cause over the 5 years of this study (Table 7). Of these,
383,646 hospital bed-days were specifically for heart
failure, with 321,281 (83.7%) of these occurring in the
first year post index admission. Of those in the first
year, 106,679 (33.2%) of the bed-days related to subjects
aged ≥85 years.Figure 1 Kaplan-Meier curves for time to heart failure
readmission and time to any readmission.Risk factors for hospital readmission
A Cox regression model indicated that the major risk
factors for any readmission were increasing age, increas-
ing Charlson score, and male gender (Table 8).
Discussion
This study used linked administrative data to provide a
picture of the typical trajectory of a heart failure patient
from the time of initial admission, and to demonstrate
the health system impacts of heart failure in New South
Wales. The most important observations were the high
rates of hospital admission to hospital, the age depend-
ence of incidence rates and the 7-8% reduction in the
rates of index admissions noted over the study period.
There is substantial morbidity after a diagnosis of heart
failure, with consequent health system impacts due to
high readmission rates for heart failure, and long dura-
tions of hospital stay, particularly in the older age
groups. Mortality was high at one year, although many
deaths were not attributed to heart failure.
Consistent with other studies [2,5,13], we demonstrated
a more than 10 fold increase in index admission rates for
those aged ≥65 years compared to those aged 45–64 years.
Incidence rates were higher for males than females at all
ages, though the longer female life expectancy meant there
were more females than males in the cohort in the oldest
age groups (≥ 80 years). Age-standardised rates decreased
over time in both males and females, a finding consistent
with other studies and settings [7,14-16].
Direct comparisons of our estimates with other studies
are challenging because of differences in the data sources
used and the standardisation applied. Based on 4812
index admissions for heart failure between 2002 and
2005 in Western Australia, Teng et al [7] concluded age-
standardised admission rates for heart failure of 249/
100,000 and 176/100,000 for men and women respect-
ively, with 41% of admissions in those aged <75 years.
We found only 34% of index heart failure admissions
were in those aged <75 years, and our age standardised
rates were higher at 257 and 235 per 100,000 for males
and females respectively in 2002–3, the first year of our
analysis. Our standardisation was only for those aged
≥45 years as heart failure before the age of 45 is likely to
be due to different aetiology, e.g. congenital heart dis-
ease; Teng et al used the population aged ≥20 years for
the denominator and a look back period of 10 years to
ensure first admission for heart failure, the limitations of
our dataset meant we could only apply a two year look
back period.
Najafi and colleagues [5] used Australian national data
for 2003–4 on all episodes of care for heart failure (both
index admissions and readmissions) and age adjustment
based on a ‘European’ population standard to derive age-
standardised separation rates for heart failure as principal
Table 5 Proportion of readmissions attributed to heart failure within 28 days and one year of the index admission
Age Group Readmissions within 28 days Readmissions within 1 year
Any cause Heart Failure* % of readmissions Any cause Heart Failure* % of readmissions
Whole population 7415 3007 41 18493 7848 40
45 – 49 107 36 34 221 80 36
50 – 54 155 48 31 366 124 34
55 – 59 288 76 36 663 219 33
60 – 64 423 131 31 1012 378 37
65 – 69 598 210 35 1447 575 40
70 – 74 905 321 36 2274 911 40
75 – 79 1297 496 38 3453 1425 41
80 – 84 1565 656 42 3985 1717 43
85+ 2077 1033 50 5072 2419 48
* heart failure or hypertensive heart disease as principal separation code.
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100,000 person-years for females. Using similar US hos-
pital discharge data standardised to the 2000 US popula-
tion, Fang et al [2] reported age-adjusted hospitalisation
rates of 390 per 100,000, more than double the Australian
estimate. These discrepancies likely reflect the methodo-
logical differences in coding procedures, admission pol-
icies, and differences in treatment thresholds and
practices.Co-morbidities
The median number of co-morbidities recorded for our
cohort was low, regardless of whether the Charlson
Index was based on records for the index admission
only, or including admissions in the previous two years
[17]. Despite likely under-reporting of co-morbidities in
the APDC [18], our data showed similar co-morbidity
profiles to those reported elsewhere [2,19]. The three
most commonly recorded co-morbidities in our data setFigure 2 Kaplan-Meier curves for time to death for each 5 year
age group for patients over 45 year of age.were diabetes (27%), pulmonary disease (15.4%) and
renal failure (14.2%). These co-morbidities are predictors
of higher patient treatment costs, particularly in the last
six months of life [20,21]. In our study, increasing age,
increasing Charlson comorbidity score and male gender
were risk factors for hospital readmission.Hospital readmission and deaths
Overall readmission rates were high. We found readmis-
sion rates of 27% at 28 days for any cause (73% at one
year) and 11% for admissions due to heart failure (32% at
one year) with strong age-related trends. Our estimate of
32% heart failure readmissions at one year is likely to be
an underestimate as we only counted readmissions
where heart failure was the principal separation code.
Overall mortality rates were 10% at 28 days and 28% at
one year, similar to those reported by Teng et al (30-day
and one year mortality rates 9.5% and 26.7% respectively)
in Western Australia [7] and by Bueno et al in a US
Medicare population (30-day mortality rate 10.7% in
2006) [22]. Mortality rates increased consistently with
age, and the poor heart failure prognosis was most
marked in the older age groups.Length of stay (LOS)
The mean LOS for the index admission for the entire co-
hort was 7.8 days, and increased with increasing age, both
for the index admission and for readmissions (all cause and
for heart failure). Our estimates are higher than some US
estimates (mean LOS 4–5 days [1], and 6.4 days in a
Medicare population [22]), although comparable to LOS
reported in the UK (median LOS 7 days for those aged <75
years and 8 days for those aged ≥75 years [23]). The mean
duration of readmissions for heart failure was longer than
for any cause and, for most age-groups comparable to the
duration of the index admission. This highlights the need to
Table 6 Mean length of stay in days for index admission
and readmissions
Age group Number of
patients












29161 7.8 (18.1) 4.8 (12.1) 8.3 (12.1)
45 – 49
years
352 5.9 (6.5) 2.1 (6.0) 5.7 (7.6)
50 – 54 604 6.3 (7.9) 2.7 (5.5) 7.0 (7.2)
55 – 59 1009 5.9 (6.7) 2.4 (6.1) 8.0 (12.1)
60 – 64 1594 6.2 (6.0) 3.3 (7.5) 7.4 (8.3)
65 – 69 2244 6.6 (7.2) 3.6 (8.1) 7.9 (9.4)
70 – 74 3548 6.9 (7.8) 3.9 (9.0) 8.1 (9.8)
75 – 79 5240 7.2 (7.3) 4.7 (11.5) 8.2 (12.3)
80 - 84 6191 7.6 (9.5) 6.0 (12.8) 8.4 (9.5)
85+ 8379 9.6 (31.2) 8.5 (20.4) 9.0 (15.8)
* heart failure or hypertensive heart disease as principal separation code.
Table 7 Hospital bed-days occupied during study period (200








60-64 Male 1 068
Female 526
65-69 Male 1 374
Female 870
70-74 Male 2 015
Female 1 533
75-79 Male 2 830
Female 2 410
80-84 Male 2 971
Female 3 220
85+ Male 3 050
Female 5 329
Total Male 14 604
Female 14 557
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larly the oldest patients.Bed-day usage
Use of acute hospital resources was substantial, with the
patients occupying almost 200,000 bed-days per year in
NSW over the five year study period. Of these, around
77,000 bed-days per year were attributed to admissions
(index or readmissions) where heart failure was the
principal separation diagnosis. Had we included read-
missions where heart failure was an additional diagnosis
and contributory factor, our estimates would have been
even higher. Most notable is the impact of the disease
on the elderly. The bed-days analysis included 8,370
patients aged ≥85 years. In the first year (index and
readmissions), these patients accounted for 106,679
acute hospital bed-days and around 60% of these were
for elderly women (66,920/106,679), reflecting the
higher proportion of women in the older age groups and
the longer LOS for these patients.Typical patient and typical trajectory
This unique dataset allows us to formulate a “typical” heart
failure patient and “typical” trajectory from first hospital2–2007)




readmissions for heart failure
7 799 2 121
3 803 1 117
9 484 3 739
5 587 2 133
24 613 7 489
12 247 3 852
36 294 12 262
17 004 5 737
48 279 17 634
30 220 10 182
65 630 24 480
55 206 19 534
96 495 36 486
84 129 31 738
98 375 39 050
108 054 44 089
95 002 46 032
156 667 75 971
481 971 189 293
472 917 194 353
Table 8 Cox regression models with time to any









Female 0.95 0.92, 0.98 0.93 0.89, 0.96 <.0001
Age Group
< 55 1 1
55-59 1.10 0.99, 1.22 1.03 0.90, 1.18 0.6189
60-64 1.07 0.98, 1.18 1.00 0.89, 1.13 0.9971
65-69 1.12 1.03, 1.23 1.03 0.92, 1.16 0.5847
70-74 1.12 1.03, 1.22 1.05 0.94, 1.17 0.3873
75-79 1.21 1.12, 1.31 1.12 1.00, 1.24 0.0437
80-84 1.22 1.12, 1.32 1.15 1.03, 1.28 0.0101
85+ 1.23 1.13, 1.33 1.14 1.02, 1.27 0.0167
Charlson Index 1.06 1.06, 1.07 1.07 1.06, 1.09 <0.0001
Index Length
of stay
1.00 1.00, 1.00 1 1.00, 1.00 0.0006
Hypertension
No 1 1
Yes 1 0.97, 1.02 0.98 0.95, 1.02 0.4133
Depression
No 1
Yes 1.01 0.91, 1.12 0.99 0.85, 1.14 0.8582
* models were adjusted for age, sex, marital status, ARIA category, SEIFA
quintile, financial class, hospital type, Charlson Index, length of stay,
hypertension, depression.
† P-values and confidence intervals calculated in SAS.
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decision makers.
The typical patient is aged over 75 years, more
likely to be female at this age, and with two co-mor-
bidities, although the incidence has been decreasing
over the last 5 years. Given that the burden of disease is
in the elderly, prevention is the key to controlling this
condition. The reduction in CHF may be partly due to
the fall in AMI [14], better control of hypertension [24],
and adherence to evidence-based guidelines for the man-
agement of chronic heart failure [25].
There is a high all cause re-admission rate, with
27% of patients being readmitted within the first 28
days, and 73% readmitted in the first year; on average
40% of these readmissions are due to CHF, and those
readmissions are longer (8.3 days) than the initial ad-
mission (7.8 days). These figures suggest that chronic
disease management plans are important to educate
patients about controlling CHF. Community based out-
reach programs may be nurse-led interventions or in-
volve multidisciplinary teams, with evidence that theseheart failure specific management programs can reduce
mortality and improve quality of life [26]. However, these
multifaceted interventions may not always reduce re-
admission rates [27], and a large US trial of telemonitor-
ing of heart failure patients failed to show differences in
readmissions for any reason or death from any cause
with this enhanced patient surveillance [28].
Patients with CHF use 200,000 bed-days per year in
a state with a population of around 6 million people;
over 80% of these bed days in the first year after the
index admission. Failure to adequately stabilise patients
before hospital discharge risks early re-admission and,
particularly in the elderly, the duration of re-admissions
can be long. With hospitals under cost and bed-occu-
pancy pressures, these impacts can be substantial. Inten-
sive specialist clinics and outpatient programs within the
first few weeks of first hospital admission may be able to
reduce this burden on the hospital system.
Median survival from time of initial diagnosis for
CHF is 1.5 years for those aged >85 and about 3 years
for those aged 80–85. This prognosis is similar to many
cancers [29], and highlights the need to address palliative
care issues in the management of CHF. Recent studies
indicate that medical admissions tend to be concentrated
in the last 6 months of life, at least in US settings
[20,21], and better palliative care programs and more
hospice places may avert these acute admissions.
Limitations and strengths of the study
This study shares the limitations of other data linkage
studies, with reliability of study conclusions dependent
on the accuracy of the record linkage, the study defini-
tions used and the validity of the coding in the hospital
records. A technical assessment of the record linkage
quality for this project determined a false positive rate
(invalid links) of 0.3% and a false negative rate (missed
links) of <0.1%. The administrative data sets used in this
study contained no information on the medical manage-
ment of heart failure, in particular use of drugs such as
ACE inhibitors, angiotensin receptor blockers and beta-
blockers that have been shown to improve long-term
survival.
Examining heart failure presents a particular challenge
as it is not a clearly defined disease entity but rather a
complex clinical syndrome often following a history of
cardiovascular disease or as a complication of diabetes,
resulting in ambiguity in its diagnosis and reporting in
medical records and hospital separation data. We chose
to present readmissions for any cause and those due to
heart failure because of the greater reliability of the cod-
ing for disease in the primary diagnosis position [30].
We did not refer to the original medical records to con-
firm a diagnosis of heart failure in the study subjects.
However a recent validation study conducted in Western
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dictive value of 99.5% with a coding of heart failure in
the principal diagnostic position [6].
The major strength of this study is that patient-level
analyses allowed us to calculate readmission rates, me-
dian survival and importantly, quantify the strong age-
related trends in incidence of disease, LOS and mortality.
Record linkage studies based on the data sets of the
CHeReL have no selection biases; analyses are based on
records of hospital separations for all residents of NSW
in both public and private hospitals.
Conclusions
We found that rates of index admissions for heart failure
decreased significantly in both males and females over the
study period. Rates of hospital readmission were high and
were related to age and the presence of co-morbidities.
LOS was longest in the oldest patients and duration of stay
similar for both index admissions and readmissions for
heart failure. Use of acute hospital resources was substan-
tial, with heart failure patients occupying almost 200,000
bed-days per year in NSW over the five year study period.
The strong age-related trends observed have implications
for policy planners and decision makers and highlight the
importance of stabilising elderly patients before discharge
and community-based outreach programs to better man-
age heart failure and reduce readmissions.
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